Anticlimax. No surprise. Behind the cautious results I the results that bit225 does appear to resistance to HIV.on conjunction with other.anti virals.
That might eventually result in some interest, but no super takrv off. More waiting.
Wating on some news about covid. We will see if that does anything.
unkely.that the super multiple gain is going.to arise soon not from a results of this calibre anyway.
. It needs a major investor to come.
No sign of that - but then it would be kept quiet until ready to go.
maybe Ior maybe not. Likely maybe not for some time. Then... ??? Who.lnows.
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-102
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
